"Patience is a Super Power" - "The Money is in the waiting"

Friday, August 22, 2025

Every portfolio should be anchored! Cautious investors might consider a balanced approach in uncertain times!

 


Here’s a structured report on five “anchor” stocks across different market segments that a cautious investor might hold for upside in a bull market while seeking protection in a bear market.


Anchor Stocks for a Balanced Portfolio

1. Apple (AAPL) – Technology

  • Rationale: Apple is the world’s largest company by market cap and a core anchor in the tech sector. Its strong ecosystem (iPhone, iPad, Mac, Services) provides recurring revenue, and its balance sheet holds significant cash reserves.

  • Bull Market Upside: Innovation in AI, wearables, and services could expand margins and boost earnings.

  • Bear Market Protection: Strong brand loyalty, consistent cash flow, and a fortress balance sheet make Apple more resilient than most tech peers.


2. Johnson & Johnson (JNJ) – Healthcare

  • Rationale: J&J is a diversified healthcare giant with exposure to pharmaceuticals, medical devices, and consumer health products. Its products are largely non-cyclical.

  • Bull Market Upside: New drug approvals and med-tech expansion can drive growth.

  • Bear Market Protection: Healthcare demand is steady regardless of economic cycles, making JNJ a safe haven during downturns.


3. JPMorgan Chase (JPM) – Financials

  • Rationale: The largest U.S. bank, JPMorgan is well-capitalized and a leader in consumer, corporate, and investment banking.

  • Bull Market Upside: Rising deal activity, lending growth, and wealth management expansion provide earnings leverage.

  • Bear Market Protection: JPM’s diversified operations, strong liquidity, and regulatory oversight provide stability compared to smaller banks.


4. Procter & Gamble (PG) – Consumer Staples

  • Rationale: PG owns globally recognized brands like Tide, Pampers, and Gillette. Its products are essential, even in recessions.

  • Bull Market Upside: Brand pricing power and global scale allow PG to capture growth in emerging markets.

  • Bear Market Protection: Demand for household goods is steady, making PG a defensive anchor stock.


5. NextEra Energy (NEE) – Utilities / Renewable Energy

  • Rationale: NextEra is the largest U.S. utility and a global leader in renewable energy. Utilities are historically defensive, and NEE adds a growth component through clean energy investments.

  • Bull Market Upside: Expansion in renewables and infrastructure spending supports long-term growth.

  • Bear Market Protection: As a utility, demand for electricity is stable, cushioning against economic downturns.


Summary

These five anchor stocks provide a blend of:

  • Growth (Apple, JPMorgan, NextEra)

  • Stability (Johnson & Johnson, Procter & Gamble)

Together, they represent technology, healthcare, financials, consumer staples, and utilities—five distinct sectors. This diversification helps cautious investors ride the bull market while softening the blow of a bear market.


Here’s the expanded report with valuation metrics for each of the five anchor stocks, plus one ETF recommendation that complements them.


Anchor Stocks for a Balanced Portfolio

1. Apple (AAPL) – Technology

  • Market Cap: ~$3.2T

  • P/E Ratio: ~29

  • Dividend Yield: ~0.5%

  • Beta: ~1.2 (slightly more volatile than market)

  • Notes: Apple’s strong balance sheet ($160B+ cash) and recurring service revenue provide cushion in downturns, while AI and product refreshes fuel upside.


2. Johnson & Johnson (JNJ) – Healthcare

  • Market Cap: ~$370B

  • P/E Ratio: ~14

  • Dividend Yield: ~3.3%

  • Beta: ~0.5 (much less volatile than market)

  • Notes: One of only two U.S. companies with AAA credit rating. Its mix of pharma, medical devices, and consumer health adds resilience.


3. JPMorgan Chase (JPM) – Financials

  • Market Cap: ~$600B

  • P/E Ratio: ~11

  • Dividend Yield: ~2.3%

  • Beta: ~1.1 (close to market risk)

  • Notes: The strongest U.S. bank balance sheet, with global reach and consistent earnings power across economic cycles.


4. Procter & Gamble (PG) – Consumer Staples

  • Market Cap: ~$400B

  • P/E Ratio: ~23

  • Dividend Yield: ~2.4%

  • Beta: ~0.4 (very defensive)

  • Notes: Reliable dividend grower, 60+ years of increases. Essential products offer protection in recessions.


5. NextEra Energy (NEE) – Utilities / Renewables

  • Market Cap: ~$160B

  • P/E Ratio: ~19

  • Dividend Yield: ~2.6%

  • Beta: ~0.5 (defensive with steady cash flow)

  • Notes: Combines utility stability with renewable growth exposure, making it a rare “defensive growth” stock.


Complementary ETF: Vanguard Dividend Appreciation ETF (VIG)

  • Category: Large-cap U.S. dividend growth companies

  • Expense Ratio: 0.06% (very low)

  • Dividend Yield: ~2%

  • Volatility: Lower than S&P 500 (Beta ~0.9)

  • Why It Complements the Anchors:

    • Focuses on high-quality companies with at least 10 years of consecutive dividend growth.

    • Provides diversification across 300+ holdings, including Microsoft, J&J, PG, and PepsiCo.

    • Smooths returns in bear markets while offering upside in bull markets.


Summary

This Anchor Portfolio of five stocks (AAPL, JNJ, JPM, PG, NEE) gives exposure to tech, healthcare, financials, consumer staples, and utilities—a broad, defensive yet growth-ready mix. Adding VIG ETF layers in dividend-growth diversification, ensuring capital protection in downturns and steady upside in expansions.


Let’s add a Canadian-listed ETF that serves as a solid complement to the anchor stocks, while being easily accessible to Canadian investors.


Canadian Complementary ETF

iShares S&P/TSX 60 Index ETF (XIU.TO)

  • Category: Large-cap Canadian blue-chip stocks

  • Exchange: Toronto Stock Exchange (TSX)

  • Expense Ratio (MER): ~0.18%

  • Dividend Yield: ~3.0%

  • Beta: ~0.9 (slightly less volatile than the S&P 500)

Why XIU Works as a Complement

  • Diversification in Canadian Market: Covers Canada’s 60 largest companies (banks, energy, telecoms, consumer).

  • Bear Market Cushion: Heavy weighting in banks and utilities makes it defensive.

  • Bull Market Upside: Exposure to resource and energy companies provides growth if commodities surge.

  • Dividend Stability: Canadian banks and telecoms (RBC, TD, BCE, Telus) are strong dividend payers.

  • Liquidity: XIU is one of the oldest and most liquid ETFs in Canada.


Alternative Canadian Option (Dividend-Focused):

Vanguard FTSE Canadian High Dividend Yield Index ETF (VDY.TO)

  • MER: ~0.22%

  • Dividend Yield: ~4.3% (higher income focus)

  • Holdings: Primarily banks, pipelines (Enbridge, TC Energy), telecoms.

  • Best For: A cautious investor wanting more income stability while still participating in bull markets.


Summary and Rationalization

  • For a core Canadian anchor ETF: XIU.TO (broad, stable, diversified).

  • For extra income/dividend protection: VDY.TO.

Together with the U.S. Anchor Stocks + VIG, these ETFs give you cross-border diversification, income in downturns, and strong upside in recoveries.

Tuesday, August 19, 2025

A small, retail investor can invest in the Nuclear industry! Here are the two companies we like!

 


Investment & Business Case: 

Cameco (CCJ) & BWX Technologies (BWXT)


1. Executive Summary

The global pivot toward decarbonization, energy security, and electrification has re-ignited interest in nuclear power. Small Modular Reactors (SMRs) and advanced nuclear technologies are attracting government funding and corporate investment.

  • Cameco (CCJ) provides exposure to the uranium supply chain, underpinned by high-grade mines and its ownership in Westinghouse (eVinci SMR).

  • BWX Technologies (BWXT) provides exposure to advanced reactor technology and TRISO fuel production, with near-term demonstrations in defense and long-term civilian opportunities.

Together, CCJ and BWXT offer a balanced portfolio: secure resource leverage + leading-edge technology.


2. Market Drivers

  1. Global Energy Security: Governments are doubling down on nuclear to secure reliable, non-fossil baseload power.

  2. SMR Deployment Timelines: First units expected late 2020s–early 2030s; multi-billion-dollar addressable market.

  3. Fuel Cycle Security: U.S. and allies are reducing dependence on Russian uranium and fuel services.

  4. Decarbonization: Nuclear seen as essential to meet net-zero targets; SMRs add flexibility for industry, data centers, and remote sites.


3. Company Profiles

Cameco (CCJ, NYSE/TSE)

  • Core Business: One of the world’s largest uranium producers. Assets include McArthur River and Cigar Lake—two of the richest uranium mines globally.


  • Vertical Integration: 49% ownership of Westinghouse Electric, which:

    • Develops the eVinci microreactor (SMR).


    • Provides nuclear services and technology worldwide.

  • Strategic Strengths:

    • Leverage to uranium spot prices.

    • Western supplier at a time of geopolitical supply concerns.

    • Optionality on SMR rollout via Westinghouse stake.

  • Growth Catalyst: Saskatchewan eVinci demo (~2029) + uranium demand surge.



BWX Technologies (BWXT, NYSE)

  • Core Business: Supplies nuclear components for the U.S. Navy (submarines and carriers) — long-term, recurring revenue.

  • Advanced Nuclear:

    • Developing BANR (HTGR microreactor).


    • Manufactures TRISO fuel at commercial scale (key enabler for advanced reactors).


    • Building Project Pele microreactor for U.S. DoD, expected by 2028.


  • Diversification: Medical isotopes (cancer treatment, diagnostics).

  • Strategic Strengths:

    • First-mover in TRISO fuel supply chain.

    • Near-term government-backed demonstration projects.

    • Stable cash flows from defense business underpin riskier R&D.


4. Financial Positioning (as of mid-2025)

  • Cameco (CCJ):

    • Revenue ~$2.6B (FY2024).

    • EBITDA margin: expanding with uranium prices.

    • Balance sheet strengthened post-Westinghouse deal.

  • BWXT (BWXT):

    • Revenue ~$2.5B (FY2024).

    • High visibility of cash flows from Navy contracts.

    • R&D spending in advanced reactors supported by government funding.


5. Growth Prospects

  • Cameco:

    • Uranium demand CAGR ~3–4% through 2035.

    • Westinghouse eVinci offers SMR optionality without significant capex burden on CCJ itself.

  • BWXT:

    • First TRISO production in decades = monopoly-like positioning.

    • Project Pele success = proof-of-concept, leading to military/industrial adoption.

    • Expansion into isotopes = new healthcare revenue stream.


6. Risk Factors

  • Cameco: Uranium spot price volatility, operational risks in mining, and political risk in Canada/Kazakhstan supply chains.

  • BWXT: R&D execution risk on BANR/Project Pele, regulatory hurdles for civilian deployment, reliance on U.S. government contracts.


7. Investment Case & Portfolio Fit

Why Together?

  • Cameco = Resource + Scale
    Provides leverage to uranium price cycle, plus Westinghouse stake = exposure to one of the leading Western reactor vendors.

  • BWXT = Technology + Fuel Supply
    Provides exposure to cutting-edge TRISO fuel and advanced reactors with nearer-term demonstration milestones.

Complementarity

  • Cameco gives commodity upside + SMR optionality.

  • BWXT gives technology exposure + steady defense-backed income.

Time Horizon

  • Near term (3–5 years): BWXT benefits from Pele/DoD contracts and TRISO fuel production ramp-up.

  • Long term (5–15 years): Cameco benefits from uranium cycle + SMR adoption via Westinghouse eVinci.


8. Conclusion – The Case for a Dual Investment

Investing in Cameco + BWXT provides a synergistic play:

  • Cameco anchors the portfolio with uranium mining cash flows + SMR exposure via Westinghouse.

  • BWXT offers nearer-term exposure to reactor tech and TRISO fuel, while being de-risked by naval contracts.

This pairing balances resource leverage with technology leadership, giving investors one of the most complete exposures to the nuclear renaissance and SMR revolution.


Recommendation: A combined allocation to Cameco (uranium resource + Westinghouse SMR exposure) and BWXT (TRISO + microreactor leadership + defense stability) positions investors strongly for both the uranium supercycle and the commercialization of advanced reactors in the coming decade.


A comparison of analyst expectations for Cameco (CCJ) and BWX Technologies (BWXT) to help you evaluate potential entry points:


Analyst Price Targets & Ratings Overview

CompanyConsensus RatingCurrent PriceAvg. Target
Cameco (CCJ)Strong Buy / Buy~$73.60• TipRanks: $80.96 (+7%) TipRanks+15MarketBeat+15
• MarketBeat: $83.32 (+13%) MarketBeat
• StockAnalysis: $85.82 (+16%) 
• Fintel: $105.32 (+43%) – likely an outlier FintelModerate to strong 7% to +16%)
BWX Technologies (BWXT)Moderate Buy / Buy~$164.75• TipRanks: $178.33 (+4%) TipRanks
• MarketBeat: $154.51 (-6%) MarketBeat+4TipRanks+4
• StockAnalysis: $155.80 (−5%) StockAnalysis
• MarketWatch: $186.75 (+13–14%) MarketWatch
• Recent BofA analyst target: $220 (+~33%), Buy rating Wall Street Journal+5Barron's+5MarketBeat+5Mixed—ranging from modest upside to notable upside (up to +33%)

Key Takeaways

  • Cameco (CCJ) offers steady upside, backed by the safest score across analyst forecasts (~7–16%). The “Strong Buy” consensus reinforces confidence in its underlying uranium business and Westinghouse exposure.

  • BWXT shows a wider spread of price targets—from modest downside to a strong (+33%) upside in optimistic scenarios. The recent Bank of America target hike to $220 indicates heightened bullish sentiment tied to nuclear expansion and emerging SMR opportunities.


Investment Strategy

Diversified Exposure with Balanced Risk-Return

  • Cameco (CCJ):

    • Pros: Clear upside, stable business fundamentals, and SMR optionality through Westinghouse.

    • Entry point: Buying now leverages a relatively safe upward forecast, especially if you believe in returning uranium prices or progress on the eVinci demo.

  • BWXT (BWXT):

    • Pros: High reward potential through TRISO fuel, Project Pele, and defence contracts.

    • Cons: Greater consensus uncertainty and near-term execution risk.

    • Strategy: Position selectively for upside—consider waiting for further confirmation from upcoming earnings or Pele progress, or scaling in to moderate exposure.


Portfolio Fit

  • Cameco brings resource leverage, stable cash flows, and long-term optionality.

  • BWXT brings technological upside and nearer-term catalysts, balanced by military and government-backed stability.

Together, they form a compelling nuclear-focused core—Cameco as the foundation, and BWXT as the growth engine.


Now: let’s translate everything we’ve discussed about Cameco (CCJ) and BWX Technologies (BWXT) into a portfolio allocation decision for a $10,000 investment.


📊 Recommended Allocation

Base Case Allocation (Balanced Approach)

  • Cameco (CCJ): $6,000 (60%)

  • BWXT (BWXT): $4,000 (40%)


🔎 Why This Split?

1. Cameco (CCJ) — The Foundation (60%)

  • Uranium leverage: CCJ is a direct play on the uranium cycle. Uranium demand is highly likely to rise as SMRs and new large reactors come online.

  • Westinghouse optionality: The 49% stake in Westinghouse gives CCJ exposure to SMR deployment without the heavy capex risk.

  • Risk profile: Lower than BWXT — CCJ is profitable, with diversified uranium supply and services, making it a safer anchor in the nuclear theme.

2. BWX Technologies (BWXT) — The Upside Engine (40%)

  • TRISO fuel leadership: BWXT is the only commercial-scale TRISO fuel producer — a bottleneck technology for HTGR/advanced reactors.

  • Near-term catalysts:

    • Project Pele (DoD microreactor, ~2028).

    • Medical isotope expansion.

    • Steady Navy contracts for propulsion systems.

  • Risk profile: Higher, because its advanced reactor revenue is future-oriented, but also higher alpha potential. Analyst targets range widely, with some seeing +30%+ upside.


📈 Scenario Considerations

  • More Conservative (70% CCJ / 30% BWXT): If you prefer resource stability and want less exposure to tech execution risk.

  • More Aggressive (50% CCJ / 50% BWXT): If you want to lean into BWXT’s TRISO and microreactor catalysts, accepting volatility.


🎯 Why 60/40 Works Best

  • CCJ anchors the investment in a market already benefiting from uranium price cycles and global nuclear buildout.

  • BWXT adds differentiated exposure to TRISO fuel and SMR technology, but without letting high R&D risk dominate the portfolio.

  • A 60/40 split balances steady commodity leverage with transformative tech growth, giving you both downside protection and upside optionality.


Ed Note: 

We will be taking these initial, small positions, once we allocate funds to this market!

60% in Cameco and 40% in BWXT as a balanced way to gain exposure to both the uranium supply chain and advanced nuclear technology.

Related Articles:

Cameco Corp's Uranium is a crucial component of energy futures


Related articles from other sources:

tastylive.com/news-insights/uranium-30-cameco-bwx-2025-nuclear

Saturday, August 16, 2025

If North American consolidation in the REE/Li market is in the cards, AVL looks to be a consolidation lottery ticket!

 

 

Avalon Advanced Materials (TSX: AVL)

Consolidation Driver in the North American REE & Lithium Markets

(Some penny stocks shouldn't be overlooked. I believe AVL is one of those)


1. Strategic Position in REEs

  • Nechalacho Project (NWT, Canada):

    • One of the most advanced REE deposits in North America.

    • 2013 DFS gave an after-tax NPV of ~USD $900M (~C$1.2B).

    • Contains both light and heavy REEs critical for defense, communications, and EV motors.

    • Currently split with Vital Metals (North T Zone) → clear consolidation target for a single operator.

  • AVL’s Basal Zone holds the majority of resources, positioning the company as a natural consolidator or takeover target.


2. Strategic Position in Lithium

https://www.vmcdn.ca/f/files/nob/avalon-advanced-materials-thunder-bay-site-sign-2.png%3Bw%3D960https://www.vmcdn.ca/f/files/nob/avalon-thunder-bay-site-placement-map.png%3Bw%3D960
  • Thunder Bay Lithium Hydroxide Facility (Ontario):

    • 2024 PEA showed C$4.1B after-tax NPV and 48% IRR.

    • Only planned midstream processing hub linking Ontario/Northern lithium deposits with Southern Ontario EV/battery manufacturing.

    • A rare “ready-made” piece of infrastructure for OEMs or lithium miners seeking to capture IRA credits.

  • Lithium Deposits: Separation Rapids (Kenora), Snowbank, and Lilypad → resource pipeline for Thunder Bay facility.


3. Why Avalon is a Consolidation Prize

  • Few companies combine REE + lithium assets in one portfolio.

  • AVL offers both upstream resources (REEs, lithium deposits) and midstream processing (Thunder Bay).

  • Consolidating AVL allows a buyer to secure:

    • Long-life REE supply (Nechalacho).

    • A North American lithium hydroxide plant.

    • Eligibility for U.S./Canadian government incentives under the IRA and Canadian Critical Minerals Strategy.


4. Potential Suitors & Rationale

  • Critical Metals (CRML): Synergy with Tanbreez (Greenland); cross-Atlantic REE strategy.

  • Vital Metals (VML): Logical consolidator of Nechalacho (eliminate split ownership).

  • MP Materials (MP): U.S. REE giant; Avalon secures Canadian REE + lithium foothold.

  • Lynas Rare Earths (LYC): Expansion into North America to diversify from Australia.

  • Lithium Americas / Piedmont Lithium: Thunder Bay plant is the missing midstream link.

  • Tesla, GM, Ford: Direct EV/battery makers securing feedstock & processing capacity.


5. Buyout Valuation & Escalation Potential

  • Current Market Cap: ~C$22–25M (@ ~C$0.04/share).

  • Risk-adjusted strategic value: ~C$300–600M (C$0.50–0.85/share).

  • Likely opening bid: ~C$1/share (~C$637M).

  • If multiple suitors compete: Escalation toward C$1.75–2.10/share (~C$1.1–1.3B).

  • Extreme scenario (Tesla/MP with gov’t backing): Possible bid north of C$2/share if Thunder Bay DFS confirms economics + IRA/Defense contracts lock in demand.


6. Investment Thesis

  • Underappreciated value: Market assigns only ~C$25M to assets with multi-billion NPVs.

  • Strategic location: Canada = politically secure jurisdiction, aligned with U.S. supply-chain policies.

  • Consolidation catalyst: Split ownership at Nechalacho and fragmented lithium supply chain make AVL a natural acquisition target.

  • Bidding war potential: With REE + lithium both on the strategic critical list, more than one suitor is almost inevitable.


Conclusion

Avalon (AVL) is grossly undervalued relative to its assets. From a consolidation standpoint, it represents one of the few opportunities for REE and lithium players to secure a vertically integrated North American platform.

  • Entry today (~C$0.04/share) offers exposure to a potential 25×–50× re-rating if a takeover unfolds.

  • A realistic acquisition could settle around C$1–1.25/share, with upside to C$2/share in a competitive bidding war.


👉 In short: AVL is a textbook “strategic consolidation play” in the REE market, with built-in lithium upside. The mismatch between current valuation and strategic value makes it highly attractive for patient investors — and a natural spark for a bidding war.


The three most likely suitors (MP Materials, Lynas, and CRML) would gain by acquiring Avalon Advanced Materials (AVL), and that could push bidding toward the C$2/share mark.


Takeover Case Comparison: Who Benefits Most from Buying Avalon (AVL)?


1. MP Materials (NYSE: MP)

Profile: Largest U.S. REE producer (Mountain Pass, California), backed by U.S. defense and IRA policies.

What They Gain From AVL:

  • Nechalacho REE deposit: Adds a second North American REE source, diversifying away from Mountain Pass.

  • Thunder Bay lithium hydroxide facility: Midstream processing capacity in Canada → critical for EV battery OEM contracts.

  • Canadian footprint: Strengthens IRA eligibility and helps qualify U.S. automakers for mineral sourcing credits.

  • Geopolitical leverage: Control over both U.S. and Canadian REEs makes MP the undisputed North American champion.

Why They Might Pay Up:

  • MP has the balance sheet (US$5B+ market cap) and political support to pay C$1.50–2.00/share for AVL if it locks out Lynas or CRML and secures Canada as a “REE & lithium fortress.”


2. Lynas Rare Earths (ASX: LYC)

Profile: World’s largest REE producer outside China (Mount Weld mine, Australia), with Japanese government support.

What They Gain From AVL:

  • Nechalacho REE deposit: A second production center outside Australia → diversification + North America expansion.

  • Thunder Bay facility: Processing hub ties them into the EV battery value chain — an area where Lynas currently lacks direct presence.

  • Strategic partnerships: Japanese offtakers (Toyota, Sojitz, JOGMEC) could be extended into Canada.

  • Geopolitical insurance: A hedge against China disruptions and over-reliance on Australia/Malaysia operations.

Why They Might Pay Up:

  • Lynas is under pressure to expand capacity in Western-friendly jurisdictions.

  • Could justify C$1.25–1.75/share, possibly more if MP enters the bidding.


3. Critical Metals Corp. (NASDAQ: CRML)

Profile: Developer of the Tanbreez REE project in Greenland, currently advancing a Definitive Feasibility Study (DFS).

What They Gain From AVL:

  • Nechalacho REE deposit: Complements Tanbreez, giving CRML two of the world’s largest non-China REE resources.

  • Thunder Bay facility: Instant midstream processing — CRML’s missing piece for vertical integration.

  • Lithium exposure: Expands portfolio beyond REEs, adding lithium hydroxide production → higher relevance to EV/battery markets.

  • U.S./Canadian critical minerals politics: Strengthens case for DOE/DoD funding, partnerships, and offtake deals.

Why They Might Pay Up:

  • CRML is smaller than MP or Lynas, so financing a C$1–2/share bid would require partnerships or equity raises.

  • But the strategic synergy is enormous — owning both Tanbreez and Nechalacho could make CRML a takeover target itself later.

  • Likely to bid in the C$1.00–1.25/share range, but might stretch higher if MP/Lynas enter the fight.


Who Would Push the Bidding War Toward $2?

  • MP Materials: Most likely, because of financial capacity and U.S. strategic interest.

  • Tesla or GM/Ford (dark horses): If they step in for vertical integration and secure lithium hydroxide, they could shock the market with a C$2+ bid.

  • Lynas: Would bid aggressively if threatened by MP’s Canadian expansion.

  • CRML: May trigger the bidding, but less likely to win against giants without financial partners.


Investment Takeaway

  • AVL’s unique REE + lithium + midstream combo makes it the only Canadian consolidator play with immediate strategic relevance.

  • Base case: Takeover at C$1–1.25/share (C$637M–800M).

  • Bidding war case: Escalation to C$1.75–2.00/share (~C$1.1–1.3B).

  • Extreme upside: If OEMs or governments step in, C$2.50–3.00/share is possible, though less likely until DFS updates are complete.


👉 This is why AVL at ~C$0.04 today looks like a consolidation lottery ticket



the downside is limited, but the upside is multiples higher if a bidding war ignites

Ed Note: Disclosure: We've been acquiring shares in AVL UCU CRML

Related Articles:

REEs are critical to all cutting edge technologies now and early investors should be rewarded! We just took a small position in our 4th REE stock-CRML